Population Immunity and Polio Eradication
- PMID: 38535527
- PMCID: PMC10974847
- DOI: 10.3390/pathogens13030183
Population Immunity and Polio Eradication
Abstract
The Global Polio Eradication Initiative made immense progress after its establishment in 1988 as a consequence of high coverage with various poliovirus vaccines in all populations of the world. Problems have arisen in recent years, however, related to security issues in some countries, to the circulation of vaccine-derived polioviruses, and to the recognition that individuals with certain immune deficiencies can remain infected and infectious for many months or years. As natural infection and different vaccines have different effects on the immune system, the patterns of humoral and mucosal immunity to polioviruses in the world today are complex but are crucial to the ultimate success of the eradication initiative. This paper describes the background of the current situation and current immunological patterns and discusses their implications for managing population immunity to polioviruses in the years ahead.
Keywords: Polio; eradication; herd immunity; immunity; vaccination.
Conflict of interest statement
The author declares no conflicts of interest.
Figures
References
-
- Musgrove P. Is polio eradication in the Americas economically justified? Bull. Pan Am. Health Organ. 1988;22:1–16. - PubMed
-
- Fine P.E.M., Mulholland K., Scott J.A., Edmunds W.J. Community Protection. In: Orenstein W.A., Offit P.A., Edwards K.M., Plotkin S.A., editors. Vaccines. 8th ed. Elsevier Inc.; Philadelphia PA, USA: 2024. pp. 1063–1624. Chapter 78.
-
- Estivariz C.F., Burns C.C., Macklin G.R. Poliovirus vaccine–Live. In: Orenstein W.A., Offit P.A., Edwards K.M., Plotkin S.A., editors. Plotkin’s Vaccines. 8th ed. Elsevier Publishers; Philadelphia, PA, USA: 2024. Chapter 50.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials